OrsoBio
Palo Alto
About OrsoBio
OrsoBio is a clinical-stage biopharmaceutical company that creates therapies for patients suffering from severe metabolic disorders such as diabetes, severe dyslipidemia, lipodystrophies, and others. OrsoBio is committed to restoring energy homeostasis in patients with severe metabolic disorders, in some cases, by targeting pathways relevant to maintaining energy balance. OrsoBio revolutionizes the treatment of these disorders by addressing the underlying cause.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $129.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2024)
- Website: orsobio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orsobio-20138 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.